vivakor_8k-120909.htm
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF
REPORT (Date of earliest event reported)
December
9, 2009
VIVAKOR,
INC.
(Exact
name of Registrant as specified in its charter)
NEVADA
(State or
other jurisdiction of incorporation)
000-53535
(Commission
File Number)
26-2178141
(IRS
Employer Identification Number)
2590
Holiday Road
Suite
100
Coralville,
Iowa 52241
(Address
of principal executive offices)
(319)
625-2172
(Registrant's
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (See General Instruction A.2. below):
[_
Written communications pursuant to Rule 425 under the Securities
Act
[_
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
[_
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
[_
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
Item 1.01
Entry into a Material Definitive Agreement.
On December 9, 2009, the Company
entered into a License Agreement with Regeneca International, Inc., a Nevada
Corporation in which an officer of the Company has a minority equity
interest. The agreement exclusively licenses to Regeneca distribution
rights to a formulation developed by Vivakor and provides for the development of
future formulations by Vivakor for Regeneca. Under the terms of the agreement,
Regeneca shall be the exclusive worldwide direct-to–consumer distributor for the
current formulation as well as any future nutraceutical formulations offered to
Regeneca by Vivakor. Regeneca has committed to purchase from Vivakor a minimum
of $5 million in product over the next three years and Vivakor will receive a
15% ownership interest in Regeneca’s outstanding common stock and will be the
exclusive supplier of the licensed product to Regeneca.
Item
9.01 Financial Statements and Exhibits
(c) Exhibits
10.11 License
Agreement between Vivakor, Inc and Regeneca International, Inc. dated December
9, 2009.
99.1
Press Release dated December 10, 2009.
# #
#
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.
| |
VIVAKOR,
INC.
(Registrant)
|
|
| |
|
|
|
|
|
By:
|
/s/ Tannin
J. Fuja |
|
| |
|
Name:
Tannin J. Fuja |
|
| |
|
Title:
President and Chief Executive Officer |
|
| |
|
|
|
Date:
December 10, 2009